ArticleBMC nephrology2022

Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy.

Elżbieta Cecerska-Heryć et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.